Please login to the form below

Not currently logged in

Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator

DarzalexA round-up from pharma, biotech and healthcare

NHS England to Vertex: come clean on Orkambi offer

OrkambiVertex has offered Orkambi at an almost 90% discount to the NHS, according to BioCentury

Novartis follows Pfizer and freezes US prices this year

Novartis HQAnd still expects revenues to come in at the high end of expectations for 2018

MaxCyte gets green light for solid tumour cell therapy

MaxCyteIts first CAR therapy will be tested in patients with ovarian cancer

Daily Brief: Limited NICE recommendation for Fasenra, Urovant takes aim at an IPO, Xtandi expands use

FasenraNews from pharma, biotech and healthcare

GSK sells eczema and psoriasis drug to Dermavant for £250m

GSK - logo on buildingThe British group is selling off assets outside core therapy areas to boost R&D

Pfizer builds gap between pharma and consumer health units

Its consumer health division will become a standalone unit after lack of buyer interest

VC raises new €270m fund for European biotechs

SanderThe money will mostly go to companies working on novel therapies

Business in the USAHealth coverage across state lines

Despite a total lack of legislative wins, the new administration has made its presence felt at home and abroad

  • Ho_Ung_KimStanding out in a crowd

    Celltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars

  • HeadsThe diseased organisation

    Like humans, organisations can be afflicted by genetic disorders that hinder performance and threaten survival but these can be understood and cured

Featured jobs

Subscribe to our email news alerts


Add my company
Rainmaker Healthcare Communications

Rainmaker is an independent, award-winning communications agency with offices in London and Atlanta. Our experience across pharmaceuticals, generics, OTC, medical...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....